UnitedHealth Group Financial Statements (UNH) |
||||||||||
UnitedHealth Groupsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 01.03.2021 | 15.02.2022 | 31.12.2022 | 24.02.2023 | 31.12.2023 | 09.05.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 255 639 | 285 273 | 324 162 | 322 132 | 371 622 | 386 380 | |||
Operating Income, bln rub | 22 405 | 23 970 | 28 435 | 28 435 | 32 358 | 32 077 | ||||
EBITDA, bln rub | ? | 23 794 | 24 749 | 31 316 | 29 805 | 36 330 | 1 960 | |||
Net profit, bln rub | ? | 15 403 | 17 285 | 20 120 | 20 120 | 22 381 | 8 478 | |||
OCF, bln rub | ? | 22 174 | 22 343 | 26 206 | 26 206 | 29 068 | 3 997 | |||
CAPEX, bln rub | ? | 2 051 | 2 454 | 2 802 | 2 802 | 3 386 | 3 283 | |||
FCF, bln rub | ? | 20 123 | 19 889 | 23 404 | 23 404 | 25 682 | 714.0 | |||
Dividend payout, bln rub | 4 584 | 5 280 | 5 991 | 5 991 | 6 761 | 6 935 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
Dividend payout ratio, % | 29.8% | 30.5% | 29.8% | 29.8% | 30.2% | 81.8% | ||||
OPEX, bln rub | 44 595 | 45 682 | 84 885 | 51 182 | 97 370 | 73 495 | ||||
Cost of production, bln rub | 190 141 | 217 945 | 210 842 | 244 545 | 280 664 | 294 980 | ||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Interest expenses, bln rub | 1 663 | 1 660 | 2 092 | 2 092 | 3 246 | 2 508 | ||||
Assets, bln rub | 197 289 | 212 206 | 245 705 | 245 705 | 278 415 | 284 210 | ||||
Net Assets, bln rub | ? | 68 328 | 75 045 | 0.000 | 81 450 | 88 756 | 86 688 | |||
Debt, bln rub | 43 467 | 46 003 | 57 623 | 57 623 | 67 435 | 73 637 | ||||
Cash, bln rub | 19 781 | 23 907 | 55 822 | 27 911 | 29 628 | 32 710 | ||||
Net debt, bln rub | 23 686 | 22 096 | 1 801 | 29 712 | 37 807 | 40 927 | ||||
Ordinary share price, rub | 350.7 | 502.1 | 530.2 | 530.2 | 526.5 | 537.0 | ||||
Number of ordinary shares, mln | 949.0 | 943.0 | 950.0 | 937.0 | 928.0 | 920.9 | ||||
Market cap, bln rub | 332 795 | 473 518 | 503 671 | 496 779 | 488 564 | 494 531 | ||||
EV, bln rub | ? | 356 481 | 495 614 | 505 472 | 526 491 | 526 371 | 535 458 | |||
Book value, bln rub | -13 865 | -10 794 | 0 | -26 303 | -30 170 | -34 519 | ||||
EPS, rub | ? | 16.2 | 18.3 | 21.2 | 21.5 | 24.1 | 9.21 | |||
FCF/share, rub | 21.2 | 21.1 | 24.6 | 25.0 | 27.7 | 0.78 | ||||
BV/share, rub | -14.6 | -11.4 | 0.00 | -28.1 | -32.5 | -37.5 | ||||
EBITDA margin, % | ? | 9.31% | 8.68% | 9.66% | 9.25% | 9.78% | 0.51% | |||
Net margin, % | ? | 6.03% | 6.06% | 6.21% | 6.25% | 6.02% | 2.19% | |||
FCF yield, % | ? | 6.05% | 4.20% | 4.65% | 4.71% | 5.26% | 0.14% | |||
ROE, % | ? | 22.5% | 23.0% | 24.7% | 25.2% | 9.78% | ||||
ROA, % | ? | 7.81% | 8.15% | 8.19% | 8.19% | 8.04% | 2.98% | |||
P/E | ? | 21.6 | 27.4 | 25.0 | 24.7 | 21.8 | 58.3 | |||
P/FCF | 16.5 | 23.8 | 21.5 | 21.2 | 19.0 | 692.6 | ||||
P/S | ? | 1.30 | 1.66 | 1.55 | 1.54 | 1.31 | 1.28 | |||
P/BV | ? | -24.0 | -43.9 | -18.9 | -16.2 | -14.3 | ||||
EV/EBITDA | ? | 15.0 | 20.0 | 16.1 | 17.7 | 14.5 | 273.2 | |||
Debt/EBITDA | 1.00 | 0.89 | 0.06 | 1.00 | 1.04 | 20.9 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
CAPEX/Revenue, % | 0.80% | 0.86% | 0.86% | 0.87% | 0.91% | 0.85% | ||||
UnitedHealth Group shareholders |